Investigation the Safety and Efficacy of The Antileukotriene Agents, Montelukast, as Adjuvant Therapy in Obese Patients With Type 2 Diabetes Mellitus

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2019
The aim of the current study is to evaluate the safety and efficacy of Montelukast in treatment of obese patients with type 2 diabetes (T2DM).
Epistemonikos ID: 024194005cd365764833aa37d6f917559752f930
First added on: Nov 24, 2021